Roxanne Lagano - Apr 26, 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Executive Vice President
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol
ZTS
Transactions as of
Apr 26, 2022
Transactions value $
-$214,768
Form type
4
Date filed
4/28/2022, 04:49 PM
Previous filing
Apr 12, 2022
Next filing
Jun 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZTS Common Stock Options Exercise $85.2K +1.16K +4.91% $73.24 24.9K Apr 26, 2022 Direct F1
transaction ZTS Common Stock Options Exercise $87.9K +1K +4.04% $87.51 25.9K Apr 26, 2022 Direct
transaction ZTS Common Stock Sale -$388K -2.17K -8.38% $178.96 23.7K Apr 26, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Stock Option Options Exercise $0 -1.16K -2.52% $0.00 45.1K Apr 26, 2022 Common Stock 1.16K Direct F3, F4, F5, F6, F7
transaction ZTS Stock Option Options Exercise $0 -1K -2.23% $0.00 44.1K Apr 26, 2022 Common Stock 1K Direct F3, F5, F6, F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
F2 The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F4 1,163 options granted February 13, 2018 at an exercise price of $73.24 per option.
F5 Each option vests on the third anniversary of the date of grant.
F6 Each option expires on the tenth anniversary of the date of grant.
F7 12,801 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F8 1,004 options granted February 12, 2019 at an exercise price of $87.51 per option.
F9 12,801 options granted February 13, 2018 at an exercise price of $73.24 per option; 11,048 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.